The LGL Group, Inc. (LGL) 股票分析

公司概述

The LGL Group, Inc. is primarily engaged in the design, manufacture, and marketing of time and frequency instruments within the United States and international markets. Operating within the Technology sector and specifically the Scientific & Technical Instruments industry, the company focuses on providing precision frequency and time reference solutions. The organization employs 8 individuals and maintains a market capitalization of $45.13M, with trailing twelve-month revenue reaching $4.17M. These valuation and revenue figures indicate that the company operates as a small-cap entity with a specialized niche product offering rather than broad industrial scale.

财务健康

The company reported a trailing twelve-month revenue of $4.17M and generated a net income of $688,000, while EBITDA stood at $270,000. The significant gap between the $4.17M revenue and the $688,000 net income, alongside an EBITDA of only $270,000, reveals a cost structure where operating expenses, likely driven by R&D and specialized manufacturing, consume the majority of gross profits. Free cash flow for the period was -$3,493,375, indicating that despite profitable operations, capital expenditures or working capital requirements exceeded cash generation, which temporarily impacts financial flexibility. However, the balance sheet remains robust with cash reserves of $41.55M, significantly outweighing total debt of $247,000. The debt-to-equity ratio is 0.54, suggesting a conservative capital structure with minimal leverage risk. Liquidity is exceptionally high, evidenced by a current ratio of 50.63, which implies the company possesses ample short-term assets to cover its short-term liabilities. Regarding efficiency, the return on equity is 1.7% and the return on assets is 0.3%, metrics that reflect the capital-intensive nature of the business or the specific accounting impacts of the large cash balance on return calculations.

估值评估

The stock trades with a trailing P/E ratio of 62.73 and a forward P/E of 30.00. The substantial difference between these two metrics implies that the market expects a significant expansion in earnings in the coming year to align current valuation multiples with future profitability. The price-to-book ratio stands at 0.98, indicating that the market values the company at approximately equal to its book value rather than at a significant premium. Alternative valuation metrics include a price-to-sales ratio of 10.82 and an EV/EBITDA of 20.62, which suggest the market is willing to pay a high multiple for sales given the company's specialized position. In terms of trading range, the 52-week high is $9.74 and the 52-week low is $5.45, placing the current trading price within the established historical volatility band. The beta value is -0.04, which is an anomalous statistic indicating that the stock price movement has historically moved in the opposite direction or with negligible correlation to the broader market index.

Growth & Income

Revenue growth for the trailing twelve-month period was 5.4% year-over-year, while earnings growth is listed as N/A due to data availability constraints in the provided facts. The absence of reported earnings growth data prevents a direct comparison of growth rates between net income and revenue, though the 5.4% revenue expansion demonstrates steady top-line performance in a specialized instrument market. The company does not pay dividends, resulting in a dividend yield of N/A and a payout ratio of 0.0%. Consequently, the firm retains all generated earnings, utilizing them for operations, research and development, or to build the substantial cash reserve of $41.55M rather than distributing cash to shareholders. The overall growth and income profile is characterized by steady revenue expansion and a complete reinvestment strategy that prioritizes balance sheet strength over shareholder cash returns.